Skip to main content
. 2012 Aug 15;12:43. doi: 10.1186/1471-2466-12-43

Table 1.

Patient characteristics and outcome of unmatched ALI patients

  No Heparin n = 559 Heparin n = 164 pvalue
Age, mean (SD)
59 (17)
63 (14)
0.003
Male,% (n)
70 (389)
63 (103)
0.10
APACHE II score, mean (SD)
17.8 (6.9)
19.8 (6.5)
0.001
Medical patients,% (n)
60 (334)
71 (117)
0.007
Surgery elective,% (n)
23 (128)
19 (31)
0.28
Surgery emergency,% (n)
17 (97)
7 (16)
0.02
Medical condition
Multiple Trauma,% (n)
8 (43)
2 (3)
0.007
Sepsis,% (n)
21 (115)
18 (29)
0.42
Diabetes,% (n)
14 (81)
16 (27)
0.53
Liver Failure,% (n)
3 (14)
2 (4)
0.96
Hematological malignancy,% (n)
6 (35)
2 (3)
0.03
Aspiration,% (n)
5 (26)
4 (6)
0.59
Pancreatitis,% (n)
2 (12)
2 (4)
0.82
Pneumonia,% (n)
23 (129)
10 (17)
< 0.001
COPD
11 (62)
14 (23)
0.31
Auto immune disease,% (n)
6 (34)
9 (15)
0.17
Previous Myocardial infarction,% (n)
13 (72)
40 (66)
< 0.001
Immune Compromised,% (n)
11 (61)
6 (10)
0.07
Massive Transfusion,% (n)
14 (78)
12 (19)
0.43
Life support measures
Respiratory failure (MV) ,% (n)
93 (519)
95 (156)
0.42
Cardiovascular failure (MI) ,% (n)
13 (72)
40 (66)
<0.001
Co interventions
Activated Protein C,% (n)
4 (24)
1 (1)
0.02
Stress dose steroids,% (n)
42 (233)
46 (76)
0.29
Protective mechanical ventilation (<8 ml/kg) ,% (n)
54 (304)
55 (91)
0.29
Restrictive fluid strategy (net fluid balance first 7 days ≤ 0 ml) ,% (n)
36 (203)
35 (58)
0.82
Outcome
28 days mortality,% (n)
24 (134)
30 (50)
0.09
90 days mortality,% (n)
32 (181)
39 (64)
0.11
ICU-stay, median (IQR)
7 (4–13)
7 (4–13)
0.59
Hospital-stay, median (IQR) 20 (11–38) 18 (8–37) 0.13

APACHE = Acute Physiology and Chronic Health Evaluation, COPD = chronic obstructive pulmonary disease, IQR = interquartile range, MI = myocardial infarction, MV = mechanical ventilation, SD = standard deviation.